Page last updated: 2024-10-25

dantrolene and Glucosephosphate Dehydrogenase Deficiency

dantrolene has been researched along with Glucosephosphate Dehydrogenase Deficiency in 1 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Glucosephosphate Dehydrogenase Deficiency: A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Younker, D1
DeVore, M1
Hartlage, P1

Other Studies

1 other study available for dantrolene and Glucosephosphate Dehydrogenase Deficiency

ArticleYear
Malignant hyperthermia and glucose-6-phosphate dehydrogenase deficiency.
    Anesthesiology, 1984, Volume: 60, Issue:6

    Topics: Dantrolene; Glucosephosphate Dehydrogenase Deficiency; Humans; Infant; Male; Malignant Hyperthermia

1984